LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 232 filers reported holding LOXO ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $71,252,000 | -27.4% | 508,691 | -11.4% | 0.05% | -17.2% |
| Q3 2018 | $98,080,000 | +18.3% | 574,136 | +20.2% | 0.06% | +10.3% |
| Q2 2018 | $82,889,000 | +27.6% | 477,801 | -15.1% | 0.06% | +23.4% |
| Q1 2018 | $64,947,000 | +8.6% | 562,946 | -20.8% | 0.05% | +9.3% |
| Q4 2017 | $59,830,000 | -24.1% | 710,740 | -17.0% | 0.04% | -27.1% |
| Q3 2017 | $78,844,000 | +5.0% | 855,887 | -8.6% | 0.06% | +1.7% |
| Q2 2017 | $75,121,000 | +186.2% | 936,790 | +50.2% | 0.06% | +176.2% |
| Q1 2017 | $26,250,000 | +8313.5% | 623,802 | +6330.9% | 0.02% | – |
| Q4 2016 | $312,000 | +22.8% | 9,700 | 0.0% | 0.00% | – |
| Q3 2016 | $254,000 | +24.5% | 9,700 | +10.2% | 0.00% | – |
| Q2 2016 | $204,000 | – | 8,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,038,920 | $285,592,000 | 80.87% |
| DAFNA Capital Management LLC | 181,675 | $25,447,000 | 12.65% |
| Opaleye Management Inc. | 175,000 | $24,512,000 | 9.15% |
| Casdin Capital, LLC | 360,000 | $50,425,000 | 8.63% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 21,775 | $3,050,000 | 3.58% |
| Avoro Capital Advisors LLC | 325,000 | $45,523,000 | 2.72% |
| AWM Investment Company, Inc. | 70,000 | $9,805,000 | 2.13% |
| Opus Point Partners Management, LLC | 6,210 | $870,000 | 1.92% |
| Eventide Asset Management | 274,000 | $38,379,000 | 1.70% |
| Aquilo Capital Management, LLC | 24,750 | $3,467,000 | 1.68% |